Medical Product Development Process: Advanced

Medical Product Development Process: Advanced

Product Development — Applied Stage-Gate Plan, Applied 21 CFR §820.30 Design Controls, ICH Q8 QbD, V&V Planning, and Capstone Development Plan

Medical Product Development Process: Advanced

Move from foundations to applied medical-product development — author a stage-gate plan, apply 21 CFR §820.30 Design Controls and ICH Q8 QbD, integrate risk management, plan V&V, select a regulatory pathway, and deliver a complete medical-product development plan.

RAQ-600-AAdvanced32 hoursCertificate of Completion

Request information and a custom quote

Medical Product Development Process
FormatProfessional Certificate Course
LevelAdvanced
Duration32 hours
LanguageEnglish
CertificateCertificate of Completion — Aleph University
Full course trackIntroductory (16 h) + Advanced (32 h) = 48 hours
Prerequisite / Recommended Preparation

Recommended prerequisite: completion of the Introductory level for this training, or relevant professional experience subject to Aleph University review.

Overview

The Advanced level of the Aleph Medical Product Development Process course track is for professionals who already have the stage-gate, Design Controls, and ICH Q8 vocabulary covered at orientation depth and need to develop the applied skills the regulated industries expect: authoring a stage-gate plan with explicit deliverables and decision criteria at each gate; applying 21 CFR §820.30 Design Controls to a chosen medical-product program (Design Input, Design Output, Design Review, Design Verification, Design Validation, Design Transfer, Design Changes, Design History File); applying ICH Q8 Quality by Design with critical quality attributes and a control strategy; integrating ISO 14971 (devices) and ICH Q9 (pharmaceuticals) risk management decisions across the stage gates; planning verification and validation aligned with 21 CFR §820.30(f)–(g) for devices and analytical-method validation for pharmaceuticals; selecting a regulatory pathway with a defensible rationale; analyzing real recall cases for root-cause patterns tied to development-process failures; and authoring a complete medical-product development plan as a portfolio-grade deliverable.

This 32-hour Professional Certificate Course builds directly on the 16-hour Introductory level (`RAQ-600-I`). It does not repeat the stage-gate, Design Controls, or ICH Q8 vocabulary orientation. Where the Introductory level identifies stage-gate methodology, the Advanced level authors a stage-gate plan for a chosen medical-product program. Where the Introductory level identifies the FDA Design Controls clauses, the Advanced level applies them to a chosen program with documented Design Input, Design Output, and Design Review artifacts. The course is organized around a chosen-program cumulative deliverable arc — the participant selects a medical-product program in Module 1, builds development-plan content on it across Modules 2 through 8, and integrates everything into a complete medical-product development plan in the Module 9 capstone course exercise.

What you will learn
Author a stage-gate plan with explicit deliverables and decision criteria at each gate.
Apply 21 CFR §820.30 Design Controls to a chosen medical-product program.
Apply ICH Q8 Quality by Design to a chosen pharmaceutical program with critical quality attributes and a control strategy.
Integrate ISO 14971 (devices) and ICH Q9 (pharmaceuticals) risk management decisions across stage gates.
Plan verification and validation aligned with 21 CFR §820.30(f)–(g) for devices and analytical-method validation for pharmaceuticals.
Select a regulatory pathway (FDA, EU MDR / IVDR, ICH-aligned pharmaceutical pathways) with a defensible rationale.
Analyze real recall cases for root-cause patterns tied to development-process failures.
Author a complete medical-product development plan integrating all of the above on a chosen program.
course topics & modules
Professional relevance

Graduates of the Advanced course are positioned for senior applied work in product-development leadership, regulatory strategy, R&D program management, and quality program leadership at medical-device, pharmaceutical, and combination-product manufacturers; at medical-product startups; and at consultancies serving manufacturers on product-development planning. The authored medical-product development plan produced during the course is a portfolio-grade artifact.

Certificate of Completion

Participants who meet the course completion requirements receive a Certificate of Completion issued by Aleph University.

Completion of both the Introductory and Advanced levels may be reviewed by Aleph University for potential recognition within an applicable graduate pathway, subject to institutional review and applicable academic policies. Recognition is not automatic and is not guaranteed.
Frequently asked questions
Ready to discuss this course?

Tell us about your goals, audience, and timeline. Aleph University will follow up with information and a custom quote for individuals, teams, or organizations.

Available for individual participants and organization-based learning.